APA (7th ed.) Citation

S, F., AA, G., BA, S., MW, M., J, S., PJ, L., . . . MF, O. (2025). Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatric blood & cancer, 72(3), e31477. https://doi.org/10.1002/pbc.31477

Chicago Style (17th ed.) Citation

S, Fetzko, et al. "Salvage Therapy Efficacy Is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma." Pediatric Blood & Cancer 72, no. 3 (2025): e31477. https://doi.org/10.1002/pbc.31477.

MLA (9th ed.) Citation

S, Fetzko, et al. "Salvage Therapy Efficacy Is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma." Pediatric Blood & Cancer, vol. 72, no. 3, 2025, p. e31477, https://doi.org/10.1002/pbc.31477.